{"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}],"groups":[{"description":"Ixazomib 4.0 mg, capsules, orally, on Days 1, 8, 15 of a 28-day cycle until progressive disease (PD)/death or unacceptable toxicity \\[13 cycles in the Induction Phase continuing in the Maintenance Phase for up to 36 Months\\] and cyclophosphamide (CYC) 300 mg/m\\^2, tablets, orally, on Days 1, 8 and 15 of a 28-day cycle for 13 cycles or until PD/death or unacceptable toxicity and dexamethasone (DEX) 40 mg, tablets, orally, on Days 1, 8, 15 and 22 (dose reduced to 20 mg for patients \\>75 years) of a 28-day cycle for 13 cycles or until PD/death or unacceptable toxicity in participants with NDMM.","id":"BG000","title":"Ixazomib 4.0 mg + CYC 300 mg/m^2 + DEX 40 mg (NDMM)"},{"description":"Ixazomib 4.0 mg, capsules, orally, on Days 1, 8, 15 of a 28-day cycle until PD/death or unacceptable toxicity \\[13 cycles in the Induction Phase continuing in the Maintenance Phase for up to 36 Months\\] and cyclophosphamide (CYC) 400 mg/m\\^2, tablets, orally, on Days 1, 8 and 15 of a 28-day cycle for 13 cycles or until PD/death or unacceptable toxicity and dexamethasone (DEX) 40 mg, tablets, orally, on Days 1, 8, 15 and 22 (dose reduced to 20 mg for patients \\>75 years) of a 28-day cycle for 13 cycles or until PD/death or unacceptable toxicity in participants with NDMM.","id":"BG001","title":"Ixazomib 4.0 mg + CYC 400 mg/m^2 + DEX 40 mg (NDMM)"},{"description":"Ixazomib 4.0 mg, capsules, orally, on Days 1, 8, 15 of a 28-day cycle and cyclophosphamide (CYC) 300 mg/m\\^2, tablets, orally, on Days 1, 8 and 15 of a 28-day cycle and dexamethasone (DEX) 40 mg, tablets, orally, on Days 1, 8, 15 and 22 (dose reduced to 20 mg for patients \\>75 years) of a 28-day cycle until PD/death or unacceptable toxicity in participants with RRMM.","id":"BG002","title":"Ixazomib 4.0 mg + CYC 300 mg/m^2 + DEX 40 mg (RRMM)"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"5.48","value":"73.4"},{"groupId":"BG001","spread":"5.80","value":"74.1"},{"groupId":"BG002","spread":"9.85","value":"63.5"},{"groupId":"BG003","spread":"9.59","value":"68.3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"37"},{"groupId":"BG003","value":"74"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"41"},{"groupId":"BG003","value":"74"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"33"},{"groupId":"BG002","value":"75"},{"groupId":"BG003","value":"143"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"4"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"74"},{"groupId":"BG003","value":"143"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}],"title":"White"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"3"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}],"title":"Other"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}],"title":"Asian"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"1"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}],"title":"Black or African American"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.35","value":"163.5"},{"groupId":"BG001","spread":"12.47","value":"163.5"},{"groupId":"BG002","spread":"10.47","value":"165.9"},{"groupId":"BG003","spread":"11.16","value":"164.8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"77"},{"groupId":"BG003","value":"147"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","populationDescription":"Number Analyzed is the number of participants with data available for analysis.","title":"Height","unitOfMeasure":"centimeters (cm)"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"11.8","value":"73.6"},{"groupId":"BG001","spread":"17.54","value":"73.0"},{"groupId":"BG002","spread":"16.80","value":"78.1"},{"groupId":"BG003","spread":"15.99","value":"75.8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Weight","unitOfMeasure":"kilograms (kg)"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"0.17","value":"1.8"},{"groupId":"BG001","spread":"0.26","value":"1.8"},{"groupId":"BG002","spread":"0.23","value":"1.9"},{"groupId":"BG003","spread":"0.23","value":"1.8"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"34"},{"groupId":"BG002","value":"78"},{"groupId":"BG003","value":"148"}],"units":"Participants"}]}],"description":"BSA = square root (height(cm) x weight (kg) / 3600.","dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Body Surface Area (BSA)","unitOfMeasure":"meters squared (m^2)"}],"populationDescription":"Safety population was defined as all participants who received at least 1 dose of any study drug."}